Design and statistical optimization of glipizide loaded lipospheres using response surface methodology

Acta Pharmaceutica

Volumn 57, Issue 3, 2007, Pages 269-285

  Shivakumar, Hagalavadi Nanjappa ^a   Patel, Pragnesh Bharat ^a   Desai, Bapusaheb Gangadhar ^a   Ashok, Purnima ^a   Arulmozhi, Sinnathambi ^a  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

Author keywords

Factorial design; Glipizide; Lipospheres; Optimization; Response surface methodology

Indexed keywords

DRUG CARRIER; GLIPIZIDE; LIPOSPHERE; PARAFFIN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; FACTORIAL ANALYSIS; FIRST PASS EFFECT; MATHEMATICAL MODEL; MULTIPLE LINEAR REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SUSTAINED DRUG RELEASE;

EID: 34548726301     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0022-8     Document Type: Article

References (22)

1. M. Efentakis and A. Koutlis, Release of furosemide from multiple-unit and single- unit preparations containing different viscosity grades of sodium alginate, Pharm. Dev. Tech. 6 (2001) 91-98; DOI: 10.1081/PDT-100000048.
2. S. Benita, Survey of Microencapsulation Processes, in Microencapsulation: Methods and Industrial Applications, Marcel Dekker, New York 1996, pp. 1-20.
3. I. El-Gibaly and S. K. Abdel-Ghaffer, Effect of hexacosanol on the characteristics of novel sustained-release allupurinol solid lipospheres: factorial design application and product evaluation, Int. J. Pharm. 294 (2005) 33-51; DOI: 10.1016/j.ijpharm.2004.12.027.
4. J. Varrshosaz and M. Keihanfar, Development and evaluation of sustained-release propranolol wax microspheres, J. Microencaps. 18 (2001) 277-284; DOI: 10.1080/02652040010018074.
5. R. K. Verma and S. Garg, Development and evaluation of osmotically controlled oral drug delivery system of glipizide, Eur. J. Pharm. Biopharm. 57 (2004) 513-525; DOI: 10.1016/j.ejpb.2004.02.003.
6. S. Jamzad and R. Fassihi, Development of controlled release low dose class II drug-glipizide, Int. J. Pharm. 312 (2006) 24-32; DOI: 10.1016/j.ijpharm.2005.12.037.
7. th ed., Pharmaceutical Press, London 2005, pp. 324-348.
8. J. K. Patel, R. P. Patel, A. F. Amin and M. M. Patel, Formulation and evaluation of glipizide microspheres, AAPS Pharm. Sci. Tech. 6 (2005) E49-E55; DOI: 10.1208/pt 060110.
9. K. P. R. Chowdary and Y. S. Rao, Design and in vitro and in vivo evaluation of mucoadesive microcapsules of glipizide for oral controlled release, AAPS Pharm. Sci. Tech. 4 (2003) 1-6; DOI: 10.1208/pt 0040339.
10. G. A. Lewis, D. Mathieu and R. Phan Tan Lui, Response Surface Methodology, in Pharmaceutical Experimental Design, Marcel Dekker, New York 1999, pp. 185-246.
11. th ed., Williams &Wilkins, Philadelphia 2006, pp. 533-560.
12. USP XXVII, NF XXII, United States Pharmacopeial Convention, Rockville 2004.
13. T. Higuchi, Mechanisms of sustained action medications: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.
14. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35.
15. E. Karasulu, H. Y. Karasuslu, G. Ertan, L. Kirilmaz and T. Guneri, Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates, Eur. J. Pharm. Sci. 19 (2003) 99-104; DOI: 10.1016/S0928-0987(03)00048-4.
16. C. Narendra, M. S. Srinath and B. Prakash Rao, Development of three layered buccal compact containing metoprolol tartarate by statistical optimization technique, Int. J. Pharm. 304 (2005) 102-114; DOI: 10.1016/j.ijpharm.2005.07.021.
17. S. Jamzad and R. Fassihi, Role of surfactant and pH on dissolution properties of fenofibrate and glipizide - A technical note, AAPS Pharm. Sci. Tech. 7 (2006) E1-E6; DOI: 10.1208/pt 070233.
18. nd ed., Marcel Dekker, New York 1987, pp. 3-94.
19. N. Mani and H. W. Jun, Microencapsulation of a hydrophilic drug into a hydrophobic matrix using a salting-out procedure. I: Development and optimization of the process using factorial design, J. Microencapsul. 21 (2004) 125-135; DOI: 10.1080/02652040310001619776.
20. C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies, Pharm. Res. 11 (1994) 575-579; DOI: 10.1023/A: 1018931002991.
21. C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics, Pharm. Res. 8 (1991) 1377-1383; DOI: 10.1023/A: 1015845022112.
22. th ed., McGraw-Hill, New York 1991, pp. 1461-1495.